NEM enters the final stretch before its October 22 earnings with a notable divergence: the stock dipped less than 1% on the week while several close peers fell hard, and options traders have shifted to their most defensive posture in months.
The clearest story this week is in the options market. Put demand has climbed steadily since mid-August, pushing the put/call ratio to 0.85 — well above its 20-day average of 0.75 and running at a z-score of 1.4. That puts the ratio close to its 52-week high of 0.88, indicating hedging activity is near the most elevated level of the past year. The shift is gradual but consistent: the PCR sat below 0.65 through most of August and has risen almost every session since, pointing to a deliberate rather than panicked rotation into downside protection ahead of the Q3 print.
The lending market tells a contrasting story. Borrow availability for NEM is essentially unconstrained — the availability reading is at its maximum ceiling, meaning the pool of shares available to borrow dwarfs the actual short position by an extraordinary margin. Short interest has also been retreating: it fell 8% across the week to roughly 1.6% of the free float, the lowest level in the 30-day window. That is a thin short book by any measure, with a days-to-cover of under two. Cost to borrow has climbed 61% across the week to 0.53%, but the absolute level remains trivially low. The short score of 30.4 is stable and unremarkable. Taken together, the borrow market carries none of the tension that options pricing suggests — shorts are retreating, not building.
The Street remains broadly constructive but has spent the summer trimming targets. Bernstein was the most recent mover, cutting its price target to $144 from $147 earlier this week while keeping an Outperform. That follows a string of reductions from Barclays, RBC, BofA, and Jefferies over July and August — all maintaining positive ratings but adjusting for a stock that had outpaced expectations. The mean consensus target of $132.87 sits roughly 5% above the current price of $126.81, a narrower implied return than the bull case warrants but enough to keep the analyst community onside. The EV/EBITDA of 7.2x has compressed slightly over 30 days, while the P/E of 12.9x has expanded modestly as earnings estimates have moved. The EPS surprise factor rank of 69 suggests NEM has a reasonable track record of beating expectations, though forward EPS momentum — ranked in the 18th to 21st percentile on both 30- and 90-day horizons — signals that the growth story is not accelerating from here.
Insider activity deserves a mention, though its read is mixed. The CFO sold 11,445 shares at $105 on August 5 in what appears to be a discretionary transaction — not filed under a 10b5-1 plan — for proceeds of $1.2 million. The CEO sold 3,882 shares on September 1 under a pre-arranged 10b5-1 plan, which is a routine compensation mechanic rather than a conviction signal. The 90-day net across all insiders is -32,000 shares at a net value of -$3.4 million, skewed mostly by the CFO sale at lower prices. On the institutional side, BlackRock held 8.7% and Vanguard Capital Management 7.7% as of their last disclosures, with no active 13D filer on the register — ownership is large-cap passive rather than activist-driven.
Among peers, NEM is holding its relative footing. AU fell 6.5% on the week, K dropped 7.2%, and DRD gave back 9.5% — all sharper moves than NEM's sub-1% weekly decline. The most recent earnings print in late July produced a 2.7% one-day drop but a near-flat five-day outcome, suggesting the market digests NEM results quickly without sustained follow-through in either direction.
The setup heading into October 22 is therefore one of quiet repositioning: options hedging is building, the short book is contracting, and analysts are still positive but trimming ambition. The key question at the next print is whether free cash flow generation at current gold prices can justify the target resets — or whether further downward revisions bring the consensus closer to where Barclays already sits at $124.
See the live data behind this article on ORTEX.
Open NEM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
